Written and maintained by CASRAI Editorial Board
Published
On this page
Short answer
Mextra is a sterile, multi-layer superabsorbent wound dressing manufactured by Mölnlycke Health Care designed to manage moderately to heavily exuding acute and chronic wounds. It combines a hydrophilic nonwoven contact layer, an absorbent core of sodium polyacrylate particles and cellulose, and a fluid-repellent nonwoven backing that locks exudate away and prevents strike-through.
This page describes products and general use; it is not medical advice.
Definition and scope
Mextra (marketed as Mextra® Superabsorbent) is an advanced medical consumable engineered for exudate management in clinics, surgical units, and clinical research. While standard absorbent pads or traditional dressing versus bandage layers quickly saturate and release fluid under pressure, superabsorbent polymer dressings actively sequester drainage and bioburden within a stabilized core.
The U.S. Food and Drug Administration (FDA) classifies Mextra under 21 CFR 878.4018 as a Class 1 device (Product Code NAC: Dressing, wound, hydrophilic; exempt from 510(k) notification). In global medical device tracking, it carries Global Medical Device Nomenclature (GMDN) Code 44970 (Exudate-absorbent dressing, non-gel, non-antimicrobial). Within healthcare supply chain catalogs, Mextra is grouped alongside highly absorbent wound dressings for managing high-drainage wounds, including venous leg ulcers under compression, Stage 3–4 pressure injuries, and exudative surgical incisions.
How it works or how it is used in practice
Mextra Superabsorbent utilizes a multi-layer fluid-handling architecture:
- Wound contact layer: A hydrophilic nonwoven polyolefin layer rests against the wound or transfer interface, allowing fluid uptake while protecting peri-wound skin from maceration.
- Superabsorbent core: A blend of cellulose fibers and crosslinked polyacrylate polymer particles hydrates upon contact with aqueous drainage. The granules chemically bind fluid and inflammatory proteases into an internal matrix, preventing strike-back even under compression.
- Fluid-repellent backing: A breathable blue nonwoven backing acts as a hydrophobic barrier, permitting moisture vapor transmission while preventing leakage onto garments or bedding.
In clinical practice, handling follows manufacturer instructions for use (IFU):
- Orientation: Apply with the white nonwoven side to the wound and the blue backing facing outward.
- Application: Use directly as a primary dressing, or as a secondary cover over a hydrofiber wound dressing or silicone transfer net.
- Sizing and overlap: The absorbent pad must overlap intact peri-wound skin by at least 2 cm to protect wound margins.
- Handling restrictions: Never cut or puncture Mextra; severing the sealed envelope releases loose polyacrylate particles into the wound bed. Do not pack Mextra into wound cavities, where particle expansion creates pressure. Maximum wear time is up to 7 days, or when saturated.
Types or related concepts
Wound care teams contrast superabsorbent technology with alternative dressing classes:
| Dressing Category | Absorbent Mechanism | Retention Under Compression | CMS Coding Classification | Cavity Suitability |
|---|---|---|---|---|
| Superabsorbent Polymer (e.g., Mextra) | Polyacrylate granules chemically binding fluid into a gelled matrix | High (locks exudate; prevents back-flow) | Specialty Absorptive Dressing (HCPCS A6251–A6253) | Contraindicated (do not use in cavities) |
| Polyurethane Foam (e.g., silicone foam wound dressings) | Open-cell capillary absorption in polyurethane sponge | Moderate (can express fluid under high pressure) | Foam Dressing without border (HCPCS A6209–A6211) | Sheet forms contraindicated; cavity foams permitted |
| Hydrofiber Dressing | Carboxymethylcellulose fibers swelling into cohesive gel | Moderate-High (vertical wicking and gelling) | Hydrophilic / Gelling Dressing (HCPCS A6196–A6198) | Permitted (ribbon and rope formats) |
| Calcium Alginate | Ion exchange between wound sodium and dressing calcium | Moderate (requires secondary cover; gels on contact) | Alginate Dressing (HCPCS A6196–A6198) | Permitted (rope and ribbon formats) |
Where it matters for labs, clinics or supply decisions
Procurement and clinical research decisions depend on regulatory, reimbursement, and operational factors:
- CMS HCPCS reimbursement coding: Under Medicare DME MAC Policy Article A54563 and LCD L33831, Mextra is classified as a Specialty Absorptive Dressing without adhesive border. Because its fluid-repellent backing lacks an adhesive perimeter, CMS assigns codes A6251 (pad size ≤16 sq. in.), A6252 (pad size >16 to 48 sq. in.), and A6253 (pad size >48 sq. in.) rather than composite dressing codes. Medicare covers changes up to once daily for heavily exuding wounds.
- Cost-in-use economics: While superabsorbent dressings have a higher unit cost than gauze or basic foams, extending wear time up to several days reduces nurse labor hours and secondary supply costs. Buyers consult wound care supply selection criteria to deploy Mextra when exudate overwhelms standard dressings.
- Clinical trial protocol control: In trials involving venous ulcers, unmanaged exudate causes maceration, confounding wound surface area measurements. Standardizing on superabsorbent dressings ensures consistent moisture control under compression wraps.
- Packaging and inventory: Mölnlycke distributes Mextra in dimensions from 12.5 × 12.5 cm to 22.5 × 42.5 cm (models 610000–610600), packed 10 per box and 40 per case, enabling precise inventory tracking.
Common misunderstandings
Key misconceptions regarding Mextra include:
- Believing Mextra can be trimmed to fit: Cutting breaks the nonwoven seal, spilling polyacrylate granules into the wound. Clinicians must select an intact size overlapping margins by 2 cm.
- Assuming superabsorbents perform like foams: Polyurethane foams can release fluid under compression, whereas polyacrylate particles chemically lock exudate in place.
- Billing Mextra under composite dressing codes: Without an integrated adhesive border, CMS rules require billing under Specialty Absorptive Dressing codes (A6251–A6253).
- Packing Mextra into wound cavities: The IFU explicitly forbids cavity packing; expanding granules generate excess pressure in enclosed spaces.
- Applying the blue backing to the wound: The blue backing is hydrophobic. Placing it against tissue blocks absorption; the white face must always contact the wound bed.
Frequently asked questions
What is Mextra Superabsorbent used for?
Mextra Superabsorbent is indicated for moderately to heavily exuding acute and chronic wounds, including venous leg ulcers, pressure injuries, and surgical wounds, protecting peri-wound skin from maceration.
Can Mextra dressings be cut or trimmed?
No. Mextra dressings must never be cut. Trimming breaches the sealed pouch and releases polyacrylate particles into the wound bed. Select a size providing at least 2 cm of intact skin overlap.
What HCPCS billing code applies to Mextra?
Under CMS DME MAC guidelines, Mextra is billed as a Specialty Absorptive Dressing without adhesive border under HCPCS codes A6251, A6252, or A6253, depending on pad dimensions.
How long can Mextra stay on a wound?
Mextra can remain in place for up to 7 days, depending on drainage volume and clinical status. Change the dressing when exudate nears pad edges or when clinically directed.
Can Mextra be used under compression wraps?
Yes. Mextra is designed for use under compression therapy for venous leg ulcers because its polyacrylate core locks fluid inside, preventing leakage under pressure.
Sources
- Mölnlycke Health Care AB. “Mextra® Superabsorbent Instructions for Use (IFU).” PD-775013_2. Accessed November 11, 2026. https://static.molnlycke.com/pim/documents/threedx/Mextra%20Superabsorbent%20IFU%20UKCA%20updated.pdf
- Mölnlycke Health Care AB. “Mextra® Superabsorbent Product Specifications and Catalog.” Accessed November 11, 2026. https://www.molnlycke.com/products-solutions/mextra-superabsorbent/
- U.S. Food and Drug Administration (FDA). “Global Unique Device Identification Database (AccessGUDID): Mextra Superabsorbent (21 CFR 878.4018, Product Code NAC, GMDN 44970).” Accessed November 11, 2026. https://accessgudid.nlm.nih.gov/
- Centers for Medicare & Medicaid Services (CMS). “Surgical Dressings: Policy Article (A54563) and Local Coverage Determination (L33831).” DME MAC Jurisdiction B/C/D. Accessed November 11, 2026. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=54563
